TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
ODTX

Odyssey Therapeutics, Inc.

Healthcare · Biotechnology

18.10$ -0.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

Odyssey Therapeutics, Inc. (ODTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ODTX
Line item Q4 24 Q1 25 Q2 25 Q1 26 Q2 26
-34 -39 -34 -41 -35
1.3 1.3 1.3 1.2 1.0
2.7 3.0 3.7 2.6 5.7
-2.5 -5.3 2.4 -7.2 1.2
0.3 0.9 0.0 0.1 0.2
– – – 35 -211
– 0.0 0.0 0.0 0.0
6.8 0.2 119 0.5 292
20 -4.2 108 -5.7 46
-35 -40 -34 -41 -35

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?